Research study Program year 2024 Source: CMS Open Payments

M22-132 Epcoritamab PH 2 Basket Combo Study

ClinicalTrials.gov NCT05283720

Research payments

$532

6 payments

Through program year 2024, $532 in research payments was reported against M22-132 Epcoritamab PH 2 Basket Combo Study, across 6 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: NCT05283720

By program year

1 row

Year	Kind	Amount	Payments
2024	Research	$532	6

Breakdown

Who paid Research payments · program year 2024

AbbVie, Inc. $532 6 payments

Who received the money Research payments · program year 2024

Thomas Jefferson University Organisation paid for research $234 1 payment
Mount Sinai Medical Center Organisation paid for research $66 1 payment
Montefiore Medical Center Organisation paid for research $58 1 payment
Thompson Cancer Survival Center Organisation paid for research $58 1 payment
Yale University School Of Medicine Organisation paid for research $58 1 payment
Tampa General Hospital Teaching hospital · FL $58 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

6 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.